The ADVANCE Trial: Clarifying the Role of Perindopril/Indapamide Fixed-Dose Combination in the Reduction of Cardiovascular and Renal Events in Patients with Diabetes Mellitus

By Waeber Bernard  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 5, 2009-10 ,pp. : 283-291

Adis International

Access to resources Recommend Favorite

The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies

By Weder Alan B  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 275-281

Informa Healthcare

Access to resources Recommend Favorite

ACE Inhibition in Hypertension: Focus on Perindopril

By Cockcroft John R.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

ACE-Inhibition for Secondary Prevention of Cardiovascular Events—Should We Change Our Recommendation After PEACE?

By Ferrari Roberto  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 1, 2006-02 ,pp. : 11-12

Springer Publishing Company

Access to resources Recommend Favorite

Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 20-25

Bentham Science Publishers

Access to resources Recommend Favorite